PulseAugur
EN
LIVE 17:03:10

AI/ML studies surge on ClinicalTrials.gov with limited FDA oversight

By PulseAugur Editorial · [1 sources] ·

A review of studies on ClinicalTrials.gov between 2010 and 2023 revealed a significant increase in AI/ML research. Out of 3,106 studies, only 7.6% were regulated by the FDA, highlighting a gap in oversight for AI applications in healthcare. AI

IMPACT Indicates a growing trend of AI/ML adoption in healthcare research, with potential implications for regulatory frameworks.

RANK_REASON Analysis of research trends and regulatory oversight in AI/ML studies. [lever_c_demoted from research: ic=1 ai=0.7]

Read on Mastodon — fosstodon.org →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

AI/ML studies surge on ClinicalTrials.gov with limited FDA oversight

COVERAGE [1]

  1. Mastodon — fosstodon.org TIER_1 English(EN) · [email protected] ·

    AI/ML studies grow on ClinicalTrials.gov (2010-2023) 📊 3,106 studies, only 7.6% FDA-regulated # AI # ML # ClinicalTrials # FDA # HealthDisparities https:// tnyp

    AI/ML studies grow on ClinicalTrials.gov (2010-2023) 📊 3,106 studies, only 7.6% FDA-regulated # AI # ML # ClinicalTrials # FDA # HealthDisparities https:// tnyp.me/jG1jMhnS/m🙂

    LINKS jmir.org/…/e57750

RELATED ENTITIES

RELATED TOPICS